Tirzepatide
GIP/GLP-1 Dual Agonist
Size: 10mg
Volume Discounts Available
Tap a tier to auto-fill the quantity
3rd Party Tested
99.3% Purity
COA Included
Same Day Ship
Ships: Worldwide, tracked — Australia, USA, Canada & Europe in 1–2 business days · rest of the world 7 business days
For Research Use Only — Not for Human Consumption
This product is intended solely for in-vitro laboratory research. Not approved by the FDA, TGA, or any regulatory body for human or animal use.Full Disclaimer
Why pay more than a cheap import? Because you actually know what you're getting.
Overview
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This dual-action mechanism makes it a valuable research tool for investigating the interplay between these two incretin hormones in metabolic regulation. Research applications focus on understanding how concurrent GIP and GLP-1 receptor activation affects insulin secretion, glucose homeostasis, energy balance, and metabolic signalling pathways.
Research Uses
Tirzepatide is supplied exclusively for laboratory research use and has been employed in controlled experimental studies examining:
Dual incretin receptor activation studies
Insulin and glucagon secretion modulation research
Beta-cell preservation pathway investigation
Appetite and satiety signalling studies
Lipid metabolism and adipose tissue research
Comparative incretin pharmacology studies
All applications are limited to non-clinical research systems designed to elucidate fundamental biological mechanisms.
RESEARCH USE ONLY
This product is intended for laboratory research use only. Not for human or veterinary use. All studies utilising this compound must be conducted in controlled research environments by qualified personnel.
Verified Researcher Reviews
No reviews yet for this product. Be the first to review it.